P2.01-90 PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small Cell Lung Cancer Patients with or without EGFR Mutation

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1144 ◽

2018 ◽

Vol 13 (10) ◽

pp. S699-S700

Author(s):

T. Siripoon ◽

P. Incharoen ◽

N. Trachu ◽

D. Munthum ◽

K. Kamprerasart ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Predictive Biomarker ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

P3.13-16 Concomitant EML4-ALK Rearrangement and EGFR Mutation in Non-Small Cell Lung Cancer Patients: Data from Eastern Indian Hospital.

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1856 ◽

2018 ◽

Vol 13 (10) ◽

pp. S982

Author(s):

P. Mohapatra ◽

S. Bhuniya ◽

M. Panigrahi ◽

S. Patra ◽

P. Mishra ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Alk Rearrangement ◽

Lung Cancer Patients

Download Full-text

Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation

Clinical Lung Cancer ◽

10.1016/j.cllc.2020.01.011 ◽

2020 ◽

Vol 21 (3) ◽

pp. 273-280.e4 ◽

Author(s):

Ichidai Tanaka ◽

Masahiro Morise ◽

Ayako Miyazawa ◽

Yuta Kodama ◽

Yutaro Tamiya ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Platinum Based Chemotherapy ◽

Potential Benefits

Download Full-text

PD-L2 expression as a predictive biomarker for the response to anti-PD-1 drugs in non-small cell lung cancer patients

Annals of Oncology ◽

10.1093/annonc/mdy375.069 ◽

2018 ◽

Vol 29 ◽

pp. vii81

Author(s):

Shinkichi Takamori ◽

Kazuki Takada ◽

Gouji Toyokawa ◽

Koichi Azuma ◽

Tomoko Jogo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Predictive Biomarker ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Retraction note: Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients

Diagnostic Pathology ◽

10.1186/s13000-016-0562-7 ◽

2016 ◽

Vol 11 (1) ◽

Author(s):

Naeemeh Ghasemkhani ◽

Sahar Shadvar ◽

Yasamin Masoudi ◽

Amir Jouya Talaei ◽

Emad Yahaghi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Prognostic Significance ◽

Predictive Biomarker ◽

Clinicopathological Features ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Abstract 1674: Prediction of survival based on tumor size dynamics and new lesions in EGFR mutation-positive non-small cell lung cancer patients treated with gefitinib or carboplatin and paclitaxel

10.1158/1538-7445.am2019-1674 ◽

2019 ◽

Author(s):

James Dunyak ◽

Jacqueline Buros-Novik ◽

Eric Novik ◽

Hong Yan ◽

Nidal Al-Huniti

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Prediction Of Survival

Download Full-text

Abstract 1674: Prediction of survival based on tumor size dynamics and new lesions in EGFR mutation-positive non-small cell lung cancer patients treated with gefitinib or carboplatin and paclitaxel

10.1158/1538-7445.sabcs18-1674 ◽

2019 ◽

Author(s):

James Dunyak ◽

Jacqueline Buros-Novik ◽

Eric Novik ◽

Hong Yan ◽

Nidal Al-Huniti

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Prediction Of Survival

Download Full-text

Retrospective Efficacy and Safety Analysis of Erlotinib (E), Pemetrexed (P) and Docetaxel (D) in Previously Treated Non-Small-Cell Lung Cancer Patients (NSCLC) without EGFR Mutation

Annals of Oncology ◽

10.1016/s0923-7534(20)33800-x ◽

2012 ◽

Vol 23 ◽

pp. ix437 ◽

Author(s):

J. Takeshita ◽

N. Katakami ◽

A. Nishiyama ◽

H. Yoshioka ◽

M. Iwasaku ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Previously Treated

Download Full-text

Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the Christie

Lung Cancer ◽

10.1016/j.lungcan.2013.09.006 ◽

2013 ◽

Vol 82 (3) ◽

pp. 510-511 ◽

Author(s):

M. Evans ◽

Y. Summers ◽

P. Taylor ◽

M. Harris ◽

N. Bayman ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Mutation Status ◽

Lung Cancer Patients ◽

Pilot Experience

Download Full-text

WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients

Scientific Reports ◽

10.1038/srep11114 ◽

2015 ◽

Vol 5 (1) ◽

Author(s):

Di Liu ◽

Chunyan Wu ◽

Yuli Jiao ◽

Likun Hou ◽

Daru Lu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Predictive Biomarker ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Wee1 Kinase ◽

Doublet Chemotherapy

Download Full-text

P3.02b-063 Analysis of Survival in EGFR-Mutation-Positive Advanced Non-Small-Cell Lung Cancer Patients with Miliary Pulmonary Metastasis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.1730 ◽

2017 ◽

Vol 12 (1) ◽

pp. S1228-S1229

Author(s):

Kageaki Watanabe ◽

Yusuke Okuma ◽

Maki Miwa ◽

Yukio Hosomi ◽

Tatsuru Okamura

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Pulmonary Metastasis ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text